Pediatric Drugs promotes the optimization and advancement of all aspects of pharmacotherapy for healthcare professionals interested in pediatric drug therapy (including vaccines). The program of reviews and original research articles provides healthcare decision makers with clinically applicable knowledge on issues relevant to drug therapy in all areas of neonatology and the care of children and adolescents, including the pharmacology, efficacy and adverse effects of the major classes of drugs; information on newly developed drugs and drug classes; the therapeutic implications of latest research into the aetiology of pediatric conditions; and the practical management of specific clinical situations.

Pediatric Drugs offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication.

There are no publication charges for standard publishing in Pediatric Drugs; the journal offers the option of Open Access publication via Springer Open Choice (article processing charge €2,570/ US$3,260). Please click on the link below under ‘Publishing model' for further information about this service.

Journal information

Editor
  • Rod McNab
Publishing model
Hybrid. Open Access options available

Journal metrics

2.519 (2019)
Impact factor
2.329 (2019)
Five year impact factor
30 days
Submission to first decision
130 days
Submission to acceptance
82,065 (2019)
Downloads

Latest articles

This journal has 46 open access articles

About this journal

Electronic ISSN
1179-2019
Print ISSN
1174-5878
Abstracted and indexed in
  1. CNKI
  2. Current Contents/Clinical Medicine
  3. Dimensions
  4. EBSCO Academic Search
  5. EBSCO Advanced Placement Source
  6. EBSCO Biomedical Reference Collection
  7. EBSCO Discovery Service
  8. EBSCO STM Source
  9. EMBASE
  10. Google Scholar
  11. Institute of Scientific and Technical Information of China
  12. Japanese Science and Technology Agency (JST)
  13. Journal Citation Reports/Science Edition
  14. Medline
  15. Naver
  16. OCLC WorldCat Discovery Service
  17. ProQuest Central
  18. ProQuest Health & Medical Collection
  19. ProQuest Health Research Premium Collection
  20. ProQuest Medical Database
  21. ProQuest-ExLibris Primo
  22. ProQuest-ExLibris Summon
  23. Reaxys
  24. SCImago
  25. SCOPUS
  26. Science Citation Index Expanded (SciSearch)
  27. Semantic Scholar
  28. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG